Home > Insider Trading > Filing (0001562180-19-004440)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1459839	Si-Bone Inc.	SIBN	Surgical & Medical Instruments & Apparatus (3841)	262216351

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1755111	Carlton W Reckling	C/O Si-Bone, Inc. 471 El Camino Real, Suite 101 Santa Clara CA 95050	Cmo And Vp, Medical Affairs	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2019-08-20	3,930	$3.96	13,826	No	4	M	Direct
Common Stock	Disposition	2019-08-20	3,930	$20.01	9,896	No	4	S	Direct
Common Stock	Acquisiton	2019-08-21	770	$3.96	10,666	No	4	M	Direct
Common Stock	Disposition	2019-08-21	770	$20.03	9,896	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2019-08-20	3,930	$0.00	3,930	$3.96
Common Stock	Stock Option (Right to Buy)	Disposition	2019-08-21	770	$0.00	770	$3.96

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
46,324		2023-03-18	No	4	M	Direct
45,554		2023-03-18	No	4	M	Direct

Footnotes

Includes 9,562 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive on shares of the Issuer's common stock.
The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan.
The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $20.00 to $20.11, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes.
The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $20.00 to $20.18, inclusive.
The shares subject to the option vest in equal monthly installments over four years commencing on vesting commencement date, subject to Reporting Person's continued service through each relevant vesting date.